您好,欢迎访问中国农业科学院 机构知识库!

Rabies virus-based oral and inactivated vaccines protect minks against SARS-CoV-2 infection and transmission

文献类型: 外文期刊

作者: Huo, Hong 1 ; Xiao, Shuang 1 ; Wang, Jinming 1 ; Wang, Xijun 1 ; Ge, Jinying 1 ; Zhong, Gongxun 1 ; Wen, Zhiyuan 1 ; Wang, Chong 1 ; Wang, Jinliang 1 ; Wang, Han 1 ; He, Xijun 2 ; Shuai, Lei 1 ; Bu, Zhigao 1 ;

作者机构: 1.Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Anim Dis Control & Prevent, Harbin 150069, Peoples R China

2.Natl High Containment Lab Anim Dis Control & Preve, Harbin 150069, Peoples R China

3.Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Peoples R China

关键词: SARS-CoV-2; rabies virus; oral vaccine; inactivated vaccine; mink

期刊名称:JOURNAL OF INTEGRATIVE AGRICULTURE ( 影响因子:4.4; 五年影响因子:4.8 )

ISSN: 2095-3119

年卷期: 2025 年 24 卷 3 期

页码:

收录情况: SCI

摘要: Minks are highly susceptible to SARS-CoV-2, and have transmitted SARS-CoV-2 to humans. Oral immunization is one of the most promising strategies to prevent SARS-CoV-2 infection and transmission in minks. Here, we generated 3 recombinant rabies viruses (RABV), rERAG333E/S6P, rERAG333E/DS6P and rERAG333E/BA2S6P, expressing the prefusion-stabilized SARS-CoV-2 spike protein of wild-type (S6P), delta (DS6P) or BA.2 (BA2S6P) strain based on an oral rabies vaccine candidate (rERAG333E). Oral or inactivated immunization of the 3 RABVs monovalent or trivalent were safe, and induced robust RABV neutralizing antibody and cross-antibody responses against the three SARS-CoV-2 in mice and minks. The challenge tests showed that 2 doses of rERAG333E-S6P as an oral or inactivated vaccine completely protected mice against mouse-adapted SARS-CoV-2 infection in the upper and lower respiratory tracts, and largely prevented viral replication and lung damage caused by wild-type SARS-CoV-2 infection in minks. Notably, we also confirmed that 2 doses of rERAG333E-S6P as an oral or inactivated vaccine can largely protect minks against wild-type SARS-CoV-2 transmission via respiratory droplets. Our findings suggest that rERAG333E-based COVID-19 vaccines appear to be suitable oral candidates to protect minks from SARS-CoV-2 infection and transmission, and may serve as inactivated vaccines for further investigation in humans.

  • 相关文献
作者其他论文 更多>>